| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Thomas James D | Chief Financial Officer | C/O NU SKIN ENTERPRISES, INC., 75 W CENTER STREET, PROVO | /s/ Gregory Belliston as Attorney-in-Fact for James D. Thomas | 12 Feb 2026 | 0001784360 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUS | Class A Common Stock | Award | $0 | +9,847 | +7.3% | $0.000000 | 145,287 | 10 Feb 2026 | Direct | F1 |
| transaction | NUS | Class A Common Stock | Award | $0 | +47,436 | +33% | $0.000000 | 192,723 | 10 Feb 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. |
| F2 | On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. |